Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution)

Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution)

Aim: to present the results of the Expert Panel with a discussion of modern concepts of the pathogenesis of functional gastrointestinal diseases and the possibilities of multitarget therapy with trimebutine. Key points. Low-grade inflammation can be considered as a morphological substrate of funct...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, D. S. Bordin, T. L. Lapina, M. A. Livzan, A. V. Okhlobystin, E. A. Poluektova, A. S. Trukhmanov, Yu. P. Uspenskiy, Yu. O. Shulpekova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-10-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	functional gastrointestinal diseases functional biliary tract diseases low-grade inflammation visceral hypersensitivity motility cytokines trimebutine
Online Access:	https://www.gastro-j.ru/jour/article/view/1347
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathogenesis of Functional Biliary Pain and Pharmacology of Trimebutin
by: E. L. Bueverova, et al.
Published: (2024-03-01)

Inflammation, impaired motor function and visceral hypersensitivity: the main mechanisms of functional disorders of the gastrointestinal tract (materials of the Expert Council and literature review)
by: V. T. Ivashkin, et al.
Published: (2022-05-01)

Present-day pathophysiological concept of functional dyspepsia
by: I. V. Mayev, et al.
Published: (2015-09-01)

The role of esophageal and stomach motility disorders in pathogenesis of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-10-01)

Functional Disorders of the Biliary Tract and Cholelithiasis: Analysis of a Possible Relationship
by: Yu. O. Shulpekova, et al.
Published: (2024-10-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

The intestinal microbiome as a separate organ
by: Yu. O. Shulpekova
Published: (2014-12-01)

Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study
by: S. S. Kardasheva, et al.
Published: (2018-11-01)

Hymecromone Efficacy in the Treatment of Biliary Pancreatitis
by: A. V. Okhlobystin, et al.
Published: (2019-12-01)

Hymecromone Administration in Real Clinical Practice: Results of the Prospective Multicentre Observational Study in the Republic of Kazakhstan
by: A. V. Nersesov, et al.
Published: (2022-01-01)

European Society for Neurogastroenterology and Motility Consensus on Gastroparesis: What Issues Remain Unresolved?
by: A. A. Sheptulin, et al.
Published: (2022-12-01)

Biliary diseases (<i>Review of the Seventeenth Russian Gastroenterological Week proceedings, October, 10–12, 2011, Moscow</i>)
by: I. V. Mayev, et al.
Published: (2012-06-01)

Modern concept of treatment of biliary peritonitis complicated by abdominal sepsis (<i>Review of the literature</i>)
by: O. A. Tereshchenko, et al.
Published: (2013-12-01)

COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01)

Systemic immune response at gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-10-01)

Improvement of surgical treatment of an acute biliary pancreatitis at elderly and senile patients
by: V. I. Midlenko, et al.
Published: (2010-02-01)

The Role of Endoscopy in the Treatment of Biliary Complications after Orthotopic Liver Transplantation
by: Alexey V. Kurenkov, et al.
Published: (2019-03-01)

Thirteen-Year Follow-Up of a Patient with Liver Cirrhosis Resulting from the Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis: Severe COVID-19 and Liver Transplantation
by: A. Kh. Odintsova, et al.
Published: (2024-03-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

Primary biliary cirrhosis: clinical and laboratory criteria of diagnostics and up-to-date treatment
by: L. Yu. Il’chenko, et al.
Published: (2011-09-01)

Di (2-ethylhexyl) phthalate reduces sperm motility by decreasing sperm tail energy supply
by: Xiao-lu Li, et al.
Published: (2025-01-01)

Cholestasis in Chronic Liver Disease and the Role of Ademetionine in its Treatment (Literature Review and Expert Panel Resolution)
by: K. L. Raikhelson, et al.
Published: (2024-10-01)

Untangling a case of dapsone-induced acute liver injury
by: V Meghana, et al.
Published: (2025-01-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Anti-motilities and anti-biofilm effects of Ageratum conyzoides L. methanol extract
by: Eli Compaoré, et al.
Published: (2025-01-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Critical evaluation of pathogenic factors of primary biliary cirrhosis
by: A. F. Sheptulina, et al.
Published: (2013-07-01)

Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases
by: O. P. Alekseeva, et al.
Published: (2020-12-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

Evaluation of the Clinical Efficacy of Prednisolone in the Treatment of Inflammatory Bowel Diseases with Different Dosage Methods
by: O. P. Alekseeva, et al.
Published: (2023-05-01)

Bowel diseases and constipation in practice of the obstetrician and gynecologist
by: I. V. Kuznetsova, et al.
Published: (2015-03-01)

Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults
by: V. T. Ivashkin, et al.
Published: (2021-06-01)

Functional Dyspepsia and Gastroesophageal Reflux Disease: From Pathogenesis to Current Treatment Strategies
by: A. S. Trukhmanov, et al.
Published: (2024-12-01)

Consensus Meeting of European Society of Neurogastroenterology and Motility on Functional Dyspepsia (2020): Have We Dotted All the I’s?
by: A. A. Sheptulin, et al.
Published: (2021-06-01)

Administration of Sex Hormone Preparations as a Risk Factor in the Development of Intrahepatic Cholestasis of Pregnancy and Biliary Sludge in Pregnant Women
by: Yu. B. Uspenskaya, et al.
Published: (2018-09-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Modern options of application of domperidone in gastroenterology
by: A. A. Sheptulin
Published: (2012-11-01)

Biliary Atresia Treatment: Can Shear Wave Elastography Predict Kasai Procedure Outcomes?
by: Sekarsari Damayanti, Gema Ramadhan Muhammad, Rinaldhy Kshetra, Prihartono Joedo
Published: (2025-03-01)